Search Results - "Vieweg, W Victor R"

Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling? by Vieweg, W. Victor R., MD, Hasnain, Mehrul, MD, Howland, Robert H., MD, Hettema, John M., MD, PhD, Kogut, Christopher, MD, Wood, Mark A., MD, Pandurangi, Ananda K., MD

“…Abstract Recently, both the manufacturer of citalopram and the US Food and Drug Administration have warned health care providers and patients about new…”
Get full text

Possible role of vascular risk factors in Alzheimer's disease and vascular dementia by Hasnain, Mehrul, Vieweg, W Victor R

“…The contribution of vascular risk factors to Alzheimer-vascular spectrum dementias is increasingly being recognized. We provide an overview of recent…”
Get more information

Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports by Vieweg, W. Victor R., Hasnain, Mehrul, Hancox, Jules C., Baranchuk, Adrian, Digby, Geneviève C., Kogut, Christopher, Crouse, Ericka L. Breden, Koneru, Jayanthi N., Deshmukh, Anand, Pandurangi, Ananda K.

“…Rationale A recent publication asserted that even low-dose risperidone may induce corrected QT (QTc) interval prolongation up to 500 ms without drug-induced I…”
Get full text

Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs: Implications in the Elderly by Vieweg, W. Victor R., Wood, Mark A., Fernandez, Antony, Beatty-Brooks, Mary, Hasnain, Mehrul, Pandurangi, Anand K.

“…The quinidine-like effects of some antidepressant drugs (particularly tricyclic antidepressants) and many antipsychotic drugs (particularly the phenothiazines)…”
Get full text

Escitalopram and QTc prolongation by Hasnain, Mehrul, MD, Howland, Robert H., MD, Vieweg, W. Victor R., MD

Get full text

Depression, Stress, and Heart Disease in Earthquakes and Takotsubo Cardiomyopathy by Vieweg, W. Victor R., MD, Hasnain, Mehrul, MD, Mezuk, Briana, PhD, Levy, James R., MD, Lesnefsky, Edward J., MD, Pandurangi, Ananda K., MD

“…Abstract The preponderance of evidence links depressive disorder and coronary heart disease (CHD). Despite this evidence, multiple clinical trials have failed…”
Get full text

Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports by Kogut, Christopher, Crouse, Ericka Breden, Vieweg, W. Victor R., Hasnain, Mehrul, Baranchuk, Adrian, Digby, Geneviève C., Koneru, Jayanthi N., Fernandez, Antony, Deshmukh, Anand, Hancox, Jules C., Pandurangi, Ananda K.

“…Objective: In the light of the recent United States Food and Drug Administration (FDA) warning to clinicians on using previously approved doses of citalopram…”
Get full text

Pharmacological Management of Psychosis in Elderly Patients with Parkinsonism by Hasnain, Mehrul, MD, Vieweg, W. Victor R., MD, Baron, Mark S., MD, Beatty-Brooks, Mary, MA, Fernandez, Antony, MD, Pandurangi, Anand K., MD

“…Abstract Parkinsonism is a characteristic feature of Parkinson's disease and dementia with Lewy bodies and is commonly seen in Alzheimer's disease. Psychosis…”
Get full text

Assessing the Presence and Severity of Depression in Subjects with Comorbid Coronary Heart Disease by Vieweg, W. Victor R., MD, Hasnain, Mehrul, MD, Lesnefsky, Edward J., MD, Turf, Elizabeth E., PhD, Pandurangi, Ananda K., MD

“…Abstract Our understanding of how depression alters the origin and course of coronary heart disease is derived from subjective methodologies. Many psychiatric…”
Get full text

Acute Effects of Newer Antipsychotic Drugs on Glucose Metabolism by Hasnain, Mehrul, MD, R. Vieweg, W. Victor, MD

Get full text

Psychotropic Drug Considerations in Depressed Patients with Metabolic Disturbances by Vieweg, W. Victor R., MD, Levy, James R., MD, Fredrickson, Sonja K., MD, Chipkin, Stuart R., MD, Beatty-Brooks, Mary, MA, Fernandez, Antony, MD, Hasnain, Mehrul, MD, Pandurangi, Anand K., MD

“…Abstract Depression, obesity, diabetes mellitus, and the metabolic syndrome are conditions commonly treated in primary care. The prevalence of each condition…”
Get full text

Depression screening in patients with coronary heart disease: A critical evaluation of the AHA guidelines by Hasnain, Mehrul, Vieweg, W. Victor R, Lesnefsky, Edward J, Pandurangi, Ananda K

“…Abstract Objective We lack evidence that routine screening for depression in patients with coronary heart disease (CHD) improves patient outcome. This lack has…”
Get full text

Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports by Hancox, Jules C., Hasnain, Mehrul, Vieweg, W. Victor R., Crouse, Ericka L. Breden, Baranchuk, Adrian

“…Over the past year, three articles have appeared in the New England Journal of Medicine describing conflicting findings about azithromycin and cardiac safety,…”
Get full text

The Risk of Overweight in Children and Adolescents with Major Mental Illness by HASNAIN, Mehrul, VIEWEG, W. Victor R, HETTEMA, John M, COLTON, David, FERNANDEZ, Antony, PANDURANGI, Anand K

“…To survey the charts of youths with major mental illness who may constitute a high-risk group (HRG) for overweight. We reviewed the charts of youths admitted…”
Get full text

Metformin for Atypical Antipsychotic-Induced Weight Gain and Glucose Metabolism Dysregulation: Review of the Literature and Clinical Suggestions by Hasnain, Mehrul, Vieweg, W. Victor R., Fredrickson, Sonja K.

“…Individuals receiving certain atypical antipsychotic medications are at risk of gaining weight and developing metabolic problems. There are no established drug…”
Get full text

Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs by Hasnain, Mehrul, Fredrickson, Sonja K, Vieweg, W Victor R

“…Antipsychotic drug-induced weight gain and glucose dysregulation add to the cardiovascular risk of patients with schizophrenia and contribute to their early…”
Get full text

QTc Interval Prolongation and Torsade de Pointes Associated with Second-Generation Antipsychotics and Antidepressants: A Comprehensive Review by Hasnain, Mehrul, Vieweg, W. Victor R.

“…We comprehensively reviewed published literature to determine whether it supported the link between corrected QT (QTc) interval prolongation and torsade de…”
Get full text

Methadone and Torsade de Pointes: How Can We Better Understand the Association? by Hasnain, Mehrul, MD, Vieweg, W. Victor R., MD, Breden Crouse, Ericka L., PharmD, Hancox, Jules C., PhD

“…Methadone-associated QTc interval prolongation is used as a surrogate marker of its association with torsade de pointes, a potentially fatal arrhythmia…”
Get full text

Erythromycin, QTc interval prolongation, and torsade de pointes: Case reports, major risk factors and illness severity by Hancox, Jules C., Hasnain, Mehrul, Vieweg, W. Victor R., Gysel, Michael, Methot, Michelle, Baranchuk, Adrian

“…Objectives: Erythromycin is a macrolide antibiotic that is widely used for various infections of the upper respiratory tract, skin, and soft tissue. Similar to…”
Get full text

Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications by Hasnain, Mehrul, Vieweg, W. Victor R, Fredrickson, Sonja K, Beatty-Brooks, Mary, Fernandez, Antony, Pandurangi, Anand K

“…Abstract Individuals with major mental illness are a high-risk group for cardio-metabolic derangements due to genetic predisposition, developmental and…”
Get full text